LP533401 hclTph-1 inhibitor CAS# 1040526-12-2 |
2D Structure
- Atorvastatin Calcium
Catalog No.:BCC2319
CAS No.:134523-03-8
- Pitavastatin Calcium
Catalog No.:BCC3842
CAS No.:147526-32-7
- Pravastatin sodium
Catalog No.:BCC2321
CAS No.:81131-70-6
- Fluvastatin
Catalog No.:BCC1579
CAS No.:93957-54-1
- Fluvastatin Sodium
Catalog No.:BCC2317
CAS No.:93957-55-2
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1040526-12-2 | SDF | Download SDF |
PubChem ID | 102602704 | Appearance | Powder |
Formula | C27H23ClF4N4O3 | M.Wt | 562.94 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 25 mg/mL (44.41 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) | ||
Chemical Name | (2S)-2-amino-3-[4-[2-amino-6-[2,2,2-trifluoro-1-[4-(3-fluorophenyl)phenyl]ethoxy]pyrimidin-4-yl]phenyl]propanoic acid;hydrochloride | ||
SMILES | C1=CC(=CC(=C1)F)C2=CC=C(C=C2)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N.Cl | ||
Standard InChIKey | BHBWZCUMIXCDPM-CHXZROHQSA-N | ||
Standard InChI | InChI=1S/C27H22F4N4O3.ClH/c28-20-3-1-2-19(13-20)16-8-10-18(11-9-16)24(27(29,30)31)38-23-14-22(34-26(33)35-23)17-6-4-15(5-7-17)12-21(32)25(36)37;/h1-11,13-14,21,24H,12,32H2,(H,36,37)(H2,33,34,35);1H/t21-,24?;/m0./s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
LP533401 hcl Dilution Calculator
LP533401 hcl Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.7764 mL | 8.8819 mL | 17.7639 mL | 35.5278 mL | 44.4097 mL |
5 mM | 0.3553 mL | 1.7764 mL | 3.5528 mL | 7.1056 mL | 8.8819 mL |
10 mM | 0.1776 mL | 0.8882 mL | 1.7764 mL | 3.5528 mL | 4.441 mL |
50 mM | 0.0355 mL | 0.1776 mL | 0.3553 mL | 0.7106 mL | 0.8882 mL |
100 mM | 0.0178 mL | 0.0888 mL | 0.1776 mL | 0.3553 mL | 0.4441 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
LP533401 hcl is an inhibitor of Tph-1 [1].
Tryptophan hydroxylase-1 (Tph-1) is an isoenzyme of tryptophan hydroxylase and the initial enzyme in gut- and lung-derived serotonin biosynthesis. Tph-1 is mainly expressed in the gut and lung [2].
LP533401 hcl is a Tph-1 inhibitor. In rat RBL2H3 cells expressing Tph1, LP533401 (1 μM) completely inhibited serotonin production. LP533401 reduced the activity of recombinant wild-type TPH-1 by 70% by interacting with residues Tyr235 and Phe241 [1].
In rodents, LP533401 orally administration was incapable of crossing the blood-brain barrier. In mice, LP533401 (250 mg/kg) dose-dependently reduced serum serotonin concentration by 30%. In ovariectomized female C57BL6/J mice, LP533401 (10, 100, 250 mg/kg for 28 days) increased bone mass and bone-formation parameters such as osteocalcin serum concentration, osteoblast numbers and bone formation rate. Also, LP533401 dose-dependently decreased serum serotonin concentration but didn’t affect brain serotonin content. In ovariectomized female rats, LP533401 completely rescued the ovariectomy-induced osteopenia [1]. In transgenic SM22-5-HTT+ mice overexpressing 5-HT transporter (5-HTT) in smooth muscle cells and spontaneously developing pulmonary hypertension (PH), LP533401 (250 mg/kg for 21 days) significantly reduced lung and blood 5-HT levels, vascular Ki67-positive cells, distal pulmonary artery muscularization, right ventricular (RV) hypertrophy and RV systolic pressure [2].
References:
[1]. Yadav VK, Balaji S, Suresh PS, et al. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med, 2010, 16(3): 308-312.
[2]. Abid S, Houssaini A, Chevarin C, et al. Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol, 2012, 303(6): L500-508.
- Trospium chloride
Catalog No.:BCC4582
CAS No.:10405-02-4
- 8alpha-Methacryloyloxybalchanin
Catalog No.:BCN4756
CAS No.:104021-39-8
- Tussilagone
Catalog No.:BCN2770
CAS No.:104012-37-5
- Cinnamaldehyde
Catalog No.:BCN6241
CAS No.:104-55-2
- Cinnamyl alcohol
Catalog No.:BCN4967
CAS No.:104-54-1
- Anethole
Catalog No.:BCN5373
CAS No.:104-46-1
- 4-Methoxyphenylacetic acid
Catalog No.:BCN8467
CAS No.:104-01-8
- 4'-Hydroxypiptocarphin A
Catalog No.:BCN7113
CAS No.:103994-39-4
- 13-Hydroxygermacrone
Catalog No.:BCN3556
CAS No.:103994-29-2
- Ceftiofur hydrochloride
Catalog No.:BCC8911
CAS No.:103980-44-5
- Esculentic acid
Catalog No.:BCN5856
CAS No.:103974-74-9
- 15-Nor-14-oxolabda-8(17),12-dien-18-oic acid
Catalog No.:BCN1637
CAS No.:1039673-32-9
- Quinovic acid 3-O-alpha-L-rhamnopyranoside
Catalog No.:BCN1636
CAS No.:104055-76-7
- Dihydroobovatin
Catalog No.:BCN3982
CAS No.:104055-79-0
- 3',5'-Diprenylgenistein
Catalog No.:BCN3572
CAS No.:104055-80-3
- Rehmapicroside
Catalog No.:BCN2884
CAS No.:104056-82-8
- Cyclo(Ile-Val)
Catalog No.:BCN2410
CAS No.:104068-43-1
- Atipamezole hydrochloride
Catalog No.:BCC7521
CAS No.:104075-48-1
- Zolantidine dimaleate
Catalog No.:BCC6922
CAS No.:104076-39-3
- Fmoc-D-Glu(OtBu)-OH
Catalog No.:BCC3496
CAS No.:104091-08-9
- SR 95531 hydrobromide
Catalog No.:BCC6997
CAS No.:104104-50-9
- Kadsuric acid 3-methylester
Catalog No.:BCN3186
CAS No.:1041070-16-9
- Phellodendrine chloride
Catalog No.:BCN5934
CAS No.:104112-82-5
- Eldecalcitol
Catalog No.:BCC1548
CAS No.:104121-92-8